Nova seeks to cut Dow’s $517m award in Canada
21-04-2022
Canada's drug pricing plan prompts backlash
26-10-2020
UK govt backs ventilator makers against potential IP complaints
16-04-2020
27-03-2020
stockstudiox / iStockphoto.com
Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Canada, COVIS-19, compulsory licensing, medicines, drugs, ventilators, Innovative Medicines Canada, amendments